Use of ligands to GABA beta receptors
OwnerRaymond Bernasconi, Uwe Otteninventors
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of ligands to GABAB receptors for increasing neurotrophin levels in the central nervous system.
Claims12
-3. (canceled)
A method for increasing neurotrophin levels in the in the central nervous system (CNS) of a patient with Parkinson's disease, amyotrophic lateral sclerosis, or stress-induced neurodegeneration, said method comprising administering to the patient an amount of a GABAB receptor antagonist sufficient to increase neurotrophin levels in the CNS of the patient.
-11. (canceled)
A method for increasing neurotrophin levels in the central nervous system (CNS) of a patient with Parkinson's disease, comprising administering to the patient an amount of a GABAB receptor antagonist sufficient to increase neurotrophin levels in the CNS of a patient with Parkinson's disease.
A method for treating Parkinson's disease, comprising administering to a patient in need of such treatment a therapeutically effective amount of a GABAB receptor antagonist, thereby treating the patient.
Dependencies are inferred from the claim text.